This article is from
Figaro Sciences
, “The DNA revolution”.
Le Figaro
A great breakthrough that brings hope to millions of patients around the world, thanks to a revolutionary therapy based on a tool called Crispr-Cas9: in the spring of 2021, a clinical trial on patients with severe forms of sickle cell disease has been shown to be successful.
In a year and a half, the patients' symptoms subsided, and they were able to do without the blood transfusions that kept them alive.
Read also:
DNA tests banned in France: the origin rush has only just begun
Sickle cell anemia, also called sickle cell anemia, is an inherited genetic disease affecting hemoglobin.
The DNA of patients has, here, been "corrected" thanks to a new treatment developed by a biotechnology company created by the Frenchwoman Emmanuelle Charpentier.
A scientist who, precisely, received the Nobel Prize in chemistry in 2020 for the discovery of this innovative Crispr.
The tool that copies and pastes in DNA
But then… Crispr, what is it?
The name is obscure.
Its pronunciation -
"tension"
-
This article is for subscribers only.
You have 91% left to discover.
Pushing back the limits of science is also freedom.
Continue reading your article for € 1 for 2 months
I ENJOY IT
Already subscribed?
Log in